Evaluation of effects of oral nutrition enriched with Eicosapentaenoic acid(EPA) in patients underwent neoadjuvant chemo therapy for head and neck cancer.
Not Applicable
Recruiting
- Conditions
- Head and neck cancer
- Registration Number
- JPRN-UMIN000007844
- Lead Sponsor
- Juntendo University school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.with incurable other cancer 2.with obvious infectious disease 3.Uncontrollable diabetes mellitus 4.oral administration of steroid 5.with cardiac, liver, or renal failure 6.with allergy of milk and soybean 7.pregnant, lactating women or women of childbearing potential 8.with chronic inflammatory disease 9.lack of agreement 10.incidence of cerebral hemorrhage or subarachnoid hemorrhage within 1 month before registration 11.oral administration of EPA before registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method transition of nutritional condition and inflammatory reaction.
- Secondary Outcome Measures
Name Time Method length of hostpitalization adverse event rate of completion for radical therapy survival rate